Pazopanib in the management of advanced soft tissue sarcomas
about
CDK4/6 inhibitors sensitize Rb-positive sarcoma cells to Wee1 kinase inhibition through reversible cell cycle arrest.Leiomyosarcoma of the stomach with metastasis to the liver: a case report with review of the literature.Ring a ring o'roses, a patient with Kaposi's? Pazopanib, pazopanib, it might go away. Mediterranean (classic) Kaposi sarcoma responds to the tyrosine kinase inhibitor pazopanib after multiple lines of standard therapy.A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
P2860
Pazopanib in the management of advanced soft tissue sarcomas
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Pazopanib in the management of advanced soft tissue sarcomas
@ast
Pazopanib in the management of advanced soft tissue sarcomas
@en
Pazopanib in the management of advanced soft tissue sarcomas
@nl
type
label
Pazopanib in the management of advanced soft tissue sarcomas
@ast
Pazopanib in the management of advanced soft tissue sarcomas
@en
Pazopanib in the management of advanced soft tissue sarcomas
@nl
prefLabel
Pazopanib in the management of advanced soft tissue sarcomas
@ast
Pazopanib in the management of advanced soft tissue sarcomas
@en
Pazopanib in the management of advanced soft tissue sarcomas
@nl
P2093
P2860
P3181
P356
P1476
Pazopanib in the management of advanced soft tissue sarcomas
@en
P2093
Elizabeth T Loggers
Lee D Cranmer
Seth M Pollack
P2860
P304
P3181
P356
10.2147/TCRM.S84792
P407
P577
2016-01-01T00:00:00Z